Filter by
Medicinal products - Latest updates (325)
RSSRepresentatives of Patients' Associations and Clinicians: Reopening of the Call for expressions of interest for the EMA Committee for Advanced Therapies (EMA CAT)
Registration - Biosimilar medicines - Multistakeholder Event (5 December 2024)
Registration - Implementation of the Hospital Exemption in the EU and its role in boosting innovation and patient access to innovative therapies (21 November 2024)
Representatives of Patients' Associations and Clinicians: Call for expressions of interest is open for the EMA Committee for Advanced Therapies
Civil Society representatives: Call for expressions of interest is open for the EMA Management Board
Deadline extended to 30 September 2024 - Call for expressions of interest to appoint Representatives of Patients’ Organisations and Healthcare professionals for EMA PRAC
Questions and Answers Document – Regulation (EU) 536/2014 – Version 6.9, July 2024
Civil Society representatives: Call for expressions of interest is open for the EMA Management Board
Representatives of Patients' Associations and Clinicians: Call for expressions of interest is open for the EMA Committee for Advanced Therapies
Independent Scientific experts: Call for expressions of interest for the EMA PRAC Committee
The amendments of the Variation Regulation are published in the Official Journal of the European Union
Agenda and registration - Consultation conference: EU guidance on public procurement of medicines (23 May 2024)
Global Gateway: European Commission and Belgian Presidency increase their support to the African Medicines Agency
Commission proposes new measures for the better lifecycle management of medicine authorisations
Factsheet - Access to medicines in all Member States
Factsheet - Incentives to steer innovation and achieve public health objectives
Factsheet - Addressing shortages of medicines and ensuring security of supply
Factsheet - Steering innovation to address unmet medical needs
Summary record - 101st meeting of the Pharmaceutical Committee (23 November 2023)
Medicines for children 2022 annual report